GB:NCYT Stock Latest News
Company AnnouncementsNovacyt S.A. Earnings Call Signals Cost-Driven Shift1M ago
Company AnnouncementsNovacyt Updates Liquidity Agreement Trades and Voting Rights Base1M ago
Company AnnouncementsNovacyt lifts H1 revenue on diagnostics growth and Asia-Pacific deal1M ago
Company AnnouncementsNovacyt sets date for interim results and investor webinar as it highlights global diagnostics reach1M ago
Company AnnouncementsNovacyt Gains IVDR Certification for Comprehensive DPYD Pharmacogenomic Assay1M ago
Company AnnouncementsNovacyt updates market on liquidity agreement activity and total voting rights2M agoCompany AnnouncementsNovacyt Updates Liquidity Agreement Activity and Confirms Total Voting Rights3M ago
Company AnnouncementsNovacyt lifts first-half revenue as restructuring and Southern Cross deal reshape growth profile3M ago
Company AnnouncementsNovacyt Updates Market on Liquidity Agreement and Voting Rights4M ago
Company AnnouncementsNovacyt wins shareholder backing for growth-focused AGM resolutions4M ago- Company AnnouncementsNovacyt Publishes 2025 Annual Report Amid Ongoing Global Expansion4M ago
Company AnnouncementsNovacyt Sets June AGM, Pushes Advance Voting to Secure Quorum4M agoCompany AnnouncementsNovacyt Plans Major Headcount Cut to Slash Cash Burn After Expansion Drive5M ago
Company AnnouncementsNovacyt sets June date for in-person AGM and online investor presentation5M ago- Company AnnouncementsNovacyt launches enhanced DPYD assay to boost safety of chemotherapy5M ago
Company AnnouncementsNovacyt announces immediate departure of Chief Scientific Officer5M ago
Company AnnouncementsNovacyt Updates Market on Liquidity Agreement Trades and Voting Rights6M ago
Company AnnouncementsNovacyt Earnings Call Balances Progress With Cash Strain6M agoCompany AnnouncementsNovacyt beats 2025 forecasts as genomic diagnostics growth offsets RUO slowdown6M ago
Company AnnouncementsNovacyt Sets Date for 2025 Results and Highlights Strategy Behind Australian Expansion6M ago
